{"id":"ghb11l1","safety":{"commonSideEffects":[]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"anthropic-haiku","explanation":"While specific mechanistic details for GHB11L1 are limited in public literature, AVIR Green Hills Biotechnology AG focuses on viral immunotherapy and antibody-based therapeutics. The compound is likely designed to modulate immune function through antibody-mediated mechanisms, potentially targeting viral antigens or immune checkpoints relevant to infectious disease or oncology applications.","oneSentence":"GHB11L1 is a therapeutic antibody targeting a viral or cellular antigen to enhance immune response against infection or disease.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T02:38:21.426Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[]},"trialDetails":[{"nctId":"NCT01078701","phase":"PHASE2","title":"Dose Finding Study of Single Dose GHB11L1 in Healthy Adults","status":"COMPLETED","sponsor":"AVIR Green Hills Biotechnology AG","startDate":"2009-12","conditions":"Influenza, Human","enrollment":49}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["A/Brisbane/59/07(H1N1)-like delNS1 virus reassortant"],"phase":"phase_2","status":"active","brandName":"GHB11L1","genericName":"GHB11L1","companyName":"AVIR Green Hills Biotechnology AG","companyId":"avir-green-hills-biotechnology-ag","modality":"Biologic","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":true,"score":2}}